Influenza and community-acquired pneumonia interactions: The impact of order and time of infection on population patterns

American Journal of Epidemiology

Volumn 175, Issue 5, 2012, Pages 363-367

  Davis, Brian M ^a,b   Aiello, Allison E ^a,b   Dawid, Suzanne ^c   Rohani, Pejman ^a,d   Shrestha, Sourya ^a   Foxman, Betsy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

community acquired infections; influenza, human; pneumococcal infections; pneumonia

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTININ; SIALIDASE;

BACTERIUM; DISEASE INCIDENCE; DISEASE SEVERITY; DISEASE TREATMENT; INFLUENZA; INOCULATION; PATHOGENICITY; PNEUMONIA; PUBLIC HEALTH;

BACTERIAL COLONIZATION; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; INFLUENZA; MIXED INFECTION; MYCOPLASMA PNEUMONIAE; NONHUMAN; REVIEW; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS;

COINFECTION; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS;

ANIMALIA; ORTHOMYXOVIRIDAE; STREPTOCOCCUS PNEUMONIAE; SUIDAE;

EID: 84857592301     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr402     Document Type: Review

References (37)

1. McCullers JA, English BK. Improving therapeutic strategies for secondary bacterial pneumonia following influenza. Future Microbiol. 2008;3 (4):397-404.
2. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198 (7):962-970.
3. Ruiz M, Ewig S, Marcos MA, et al. Etiology of communityacquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med. 1999;160 (2):397-405.
4. McCullers JA. Insights into the interaction between influenza virus and Pneumococcus. Clin Microbiol Rev. 2006;19 (3):571-582.
5. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pedi at Rics. 2008;122 (4):805-811.
6. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289 (2):179-186.
7. Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis. 2006;194(suppl 2): S82-S91.
8. Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One. 2009;4(12):e8540. (doi:10.1371/journal.pone.0008540).
9. Hilleman MR. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine. 2002;20(25-26):3068-3087.
10. File TM. Community-acquired pneumonia. Lancet. 2003;362 (9400):1991-2001.
11. McCullers JA, McAuley JL, Browall S, et al. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis. 2010;202 (8):1287-1295.
12. Diavatopoulos DA, Short KR, Price JT, et al. Influenza Avirus facilitates Streptococcus pneumoniae transmission and disease. FASEB J. 2010;24 (6):1789-1798.
13. Weinberger DM, Trzciński K, Lu YJ, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 2009;5(6):e1000476. (doi:10.1371/journal.ppat. 1000476).
14. Wadowsky RM, Mietzner SM, Skoner DP, et al. Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect Immun. 1995;63 (4):1153-1157.
15. Schaal KP. Medical and microbiological problems arising from airborne infection in hospitals. J Hosp Infect. 1991;18(suppl A): 451-459.
16. Morawska L. Droplet fate in indoor environments, or can we prevent the spread of infection? Indoor Air. 2006;16 (5):335-347.
17. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis. 2002;186 (3):341-350.
18. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med. 1997;157 (15):1709-1718.
19. Bogaert D, van Belkum A, Sluijter M, et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet. 2004;363 (9424):1871-1872.
20. Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med. 2010;38(4 suppl):e91-e97.
21. LeVine AM, Koeningsknecht V, Stark JM. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods. 2001;94(1-2):173-186.
22. Tashiro M, Ciborowski P, Reinacher M, et al. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology. 1987;157 (2):421-430.
23. Margolis E, Yates A, Levin BR. The ecology of nasal colonization of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus: the role of competition and interactions with host's immune response. BMC Microbiol. 2010;10 (1):59. (doi:10.1186/1471-2180-10-59).
24. Klugman KP, Astley CM, Lipsitch M. Time from illness onset to death, 1918 influenza and pneumococcal pneumonia. Emerg Infect Dis. 2009;15 (2):346-347.
25. Brundage JF, Shanks GD. Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis. 2008;14 (8):1193-1199.
26. Shahangian A, Chow EK, Tian X, et al. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest. 2009;119 (7):1910-1920.
27. Lee MH, Arrecubieta C, Martin FJ, et al. A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis. 2010;201 (4):508-515.
28. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med. 2008;14 (5):558-564.
29. Giebink GS, Wright PF. Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect Immun. 1983;41 (3):913-920.
30. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med. 2009;6(5):e1000081. (doi:10.1371/journal.pmed.1000081).
31. Christenson B, Hedlund J, Lundbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J. 2004;23 (3):363-368.
32. Soto-Abraham MV, Soriano-Rosas J, Díaz-Quiñónez A, et al. Pathological changes associated with the 2009 H1N1 virus. N Engl J Med. 2009;361 (20):2001-2003.
33. Cunha B, Syed U, Strollo S. During the "herald wave" of the pandemic bacterial pneumonia relatively rare with fatal swine influenza (H1N1) pneumonia: if chest films have no focal segmental/lobar infiltrates, antibiotic therapy is unnecessary. J Chemother. 2009;21 (5):584-589.
34. Wright PF, Kirkland KB, Modlin JF. When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza associated pneumonia. N Engl J Med. 2009;361(24):e112. (doi:10.1056/NEJMopr0910749).
35. Cinti SK, Barnosky AR, Gay SE, et al. Bacterial pneumonias during an influenza pandemic: how will we allocate antibiotics? Biosecur Bioterror. 2009;7 (3):311-316.
36. Cunha BA. Swine influenza (H1N1) pneumonia: clinical considerations. Infect Dis Clin North Am. 2010;24 (1):203-228.
37. Fedson DS. Was bacterial pneumonia the predominant cause of death in the 1918-1919 influenza pandemic? J Infect Dis. 2009;199 (9):1408-1409.